- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
112 Cards in this Set
- Front
- Back
|
What are the layers of the adrenal cortex and what hormones does each layer produce?
Stimulus of each? |
GFR, deeper you go, sweeter it gets:
Renin-Ag II-->Zona glomerulosa--aldosterone ACTH, CRH-->Zona fasciculata--cortisol ACTH, CRH-->Zona reticulata--Sex hormones, androgens |
|
What does the adrenal medullar produce?
Stimulus? |
Pregnaglionic Symp Nerves-->Medulla (Chromaffin cells)-->Epi, NE
|
|
Adrenal Cortex vs Medulla:
Embryonic origin |
Cortex: Mesoderm
Medulla: NCC |
|
What is the most common adrenal medulla tumor in:
Children Adults |
Children: Neuroblastoma
Adults: Pheochromocytoma |
|
17-alpha-hydroxylase:
Role Effect of deficiency |
(Cholesterol-->Pregnenolone)
Pregnenolone-->17-hydroxypregnenolone (this is then shunted to Cortisol or T/E2 production) OR Progesterone-->17-hydroxyprogesterone (which is then shunted to cortisol, T/E2 production) Deficiency results in: -low sex hormones -low cortisol -inc'd mineralocorticoids (HTN, hypokalemia, pseudohermaphroditism--externally phenotypic female, but not internal reproductive structures due to MIF; in women causes externally phenotypic female w/normal internal sex organs but lacking secondary sex chars) |
|
21-hydroxylase:
Role Effect of deficiency |
(Cholesterol-->pregnenolone-->Progesterone)
Progesterone-->11-deoxycorticosterone OR 17-hydroxyprogesterone-->11-deoxycortisol(-->cortisol) Deficiency -->most common form of dec'd cortisol (inc'd ACTH). Dec'd mineralocorticoids, inc'd sex hormones. Sx = masculinzation, female pseudohermaphroditism, HYPOtn, hyperkalemia, inc'd renin Salt wasting, volume depletion |
|
11 beta-hydroxylase:
Role Effect of deficiency |
(Cholesterol-->pregnenolone-->Progesterone-->11-deoxycorticosterone)
11-deoxycorticosterone-->corticosterone(00>aldosterone) OR (17-hydroxyprogesterone-->21-hydroxylase-->11-deoxycortisol) 11-deoxycortisol-->Cortisol Effect of deficiency: dec'd cortisol, dec'd aldosterone, dec'd corticosterone, inc'd sex hormones; inc'd 11-deoxycorticosterone (acts as mineralocorticoid) Sx: masculinizaiton, HTN |
|
What features characterize a deficiency in 3 beta-hydroxysteroid dehydrogenase?
|
3 beta-hydroxysteroid DH essential to formation of aldosterone, cortisol, testosterone, estradiol, so:
deficiency-->inability to produce gluococorticoids, mineralocorticoids, androgens, and estrogens Results in early death and excessive salt secretion in urine |
|
Presentation of deficiency of steroid synthesis enzymes with 1 in first digit.
|
If 1 in first digit->HTN
ex: 11-beta-hydroxylase def ex: 17-alpha-hydroxylase def |
|
Presentation of deficiency of steroid synthesis enzymes with 1 in second digit.
|
If 1 in second digit-->masculinization
Ex: 21-beta hydroxylase def ex: 11-beta-hydroxylase def (doesn't matter if 1 is in first digit!!) |
|
Cortisol:
Effects Regulation |
Cortisol is BBIIG
-Maintains BP (upregulates alpha-1 receptors on arterioles) -Decreases bone formation -Anti-Inflammatory -Dec'd immune fn -Inc'd gluconeogenesis, lipolysis, proteolysis Regulation: CRH (hthal)-->ACTH (pituitary)-->cortisol production in adrenal zona fasciulata |
|
Cushing's Syndrome:
Causes Presentation |
-Exogenous steroids (dec'd ACTH)
-Cushing's DISEASE--ACTH secretion from pituitary adenoma -Ectopic ACTH from inon-pituitary tissue making ACTH (small cell lung cancer, bronchial carcinoids)--inc'd ACTH -Adrenal adenoma Presentation: HTN, weight gain, moon facies, truncal obesity, buffalo hump, hyperglycemia, striae |
|
What test can be used to distinguish causes of Cushing's syndrome?
What would you expect to see? |
Dexamethasone (synthetic gluocorticoid) suppression test:
If healthy: dec'd cortiol after low dose dexamethasone If ACTH-producing PITUITARY tumor: inc'd cortisol after low dose, dec'd cortisol after high dose If eectopic ACTH-producing tumor (e.g., small cell carcinoma)-->inc'd cortisol after low and high dose If cortisol-producing tumor: inc'd cortisol after low and high dose |
|
An adult male withe elevated serum cortisol levels and signs of Cushing's syndrome undergoes a dexamethasone suppression test.
1mg dexamethasone does not decrease cortisol levels, but 8mg does. Diagnosis? |
ACTH production pituitary tumor
|
|
Glucocorticoids:
MOA Examples AE |
MOA: dec'd production of LKs and PGs by inhibiting phospholipase A2 and expression of COX-2
Ex: hydrocortisone, prednisone (anythign ending in -sone) AE: Iatrogenic Cushing's, adrenal insufficiency if stopped after chronic use Psychosis, insomnia, glaucoma, acne |
|
Hyperaldosteronism:
Primary vs Secondary-- Causes Lab values Treatment |
Primary--aldosterone-secreting tumor resulting in HTN, hypokalemia, metabolic alkalosis, LOW RENIN
Secondary: Kidney perception of low intravascular volume results in overactive renin-Ag system. Due to renal artery stenosis, chronic renal failure, CHF; HIGH PLASMA RENIN Tx: Sx to remove tumor, spironolactone (K+ spraing aldosterone antagonist) |
|
Adrenal insufficiency:
Primary vs Secondary-- Causes Labs |
Primary = Adrenal atrophy or destruction by dz (autoimune, TB, mets); deficiency of aldosterone and cortisol-->hypotn, hyperkalemia, hyperpigmentation (due to MSH, by-product of inc'd ACTH production from POMC)
Secondary adrenal insufficiency: dec'd pituitary ACTH production--no skin hyperpigmentation, no hyperkalemia |
|
Waterhouse-Friderichsen Syndrome:
Pathophys |
Acute primary adrenal insufficiency to adrenal hemorrhage associated w/Neisseria meningitidis septicemia, DIC, endotoxic shock
|
|
Pheochromocytoma:
Pathophys Presentation Treatment |
Tumor of adrenal medulla; derived from chromaffin cells (arise from NCC); secrete NE, epi, DA-->EPISODIC HTN
Urinary VMA, plasma catechols elevated Tx: alpha-antags, esp PHENOXYBENZAMINE (nonselective irreversible alpha-blocker) followed by surgery to remove tumor Presentation: EPISODIC HTN, HA, perspiration, palpitations, pallor |
|
Neuroblastoma:
What is it? Associated mutation |
Most common tumor of adrenal medulla in children
HVA elevated in urine, less likely to develop HTN Assocd w/N-myc oncogene |
|
MEN1 vs MEN 2A vs MEN 2B:
Associated neoplasms |
MEN1: Pancreas, Pituitary, Parathyroid tumors
MEN2A: Pheochromocytoma, Parathyroid tumor MEN2B: Pheochromocytoma, mucosal neuroma ALL have Aut Dom inheritance |
|
Which MEN syndromes are associated with ret genes?
|
MEN2A, MEN2B
|
|
Islets of Langerhans:
alpha vs beta vs delta cells |
alpha: make glucagon
beta: make insulin delta: make somatostatin |
|
What cells don't require insulin for glucose uptake?
|
BRICK L
Brain RBCs Intestine Cornea Kidney Liver |
|
Nonenzymatic glycolysation:
Cause Effect |
Nonenzymatic addition of glucose to molecules due to hyperglycemia (insulin)
Results in Small vessel dz (diffuse thickening of BM)-->retinopathy, glaucoma, nephropathy Can also result in large vessel atherosclerosis, CAD, peripheral vascular occlusive dz, gangrene |
|
Diabetic glomerulosclerosis--nodular; acellular ovoid nodules in periphery of glomerulus
|
|
Diabetic retinopathy--cotton wool spots, macular edema; can also be seen in HTN
|
|
How is sorbitol formed?
Describe its metabolism. How can it result in osmotic damage? What cells are susceptible to this? |
Glucose + NADPH-->Sorbitol via ALCOHOL REDUCTASE
Sorbitol + NAD+-->Fructose via SORBITOL DEHYDROGENASE Not all cells are equipped with sorbitol DH, so in setting of DM, there's inc'd sorbitol, which (via an osmotic effect) results in neuropathy and cataracts. Cells that don't have aldose reductase: -Schwann cells, lens, retina, kidneys |
|
Pancreatic islet cells in DM1--islet cells entirely replaced by fibrosis
|
|
DKA:
Pathophys Presentation Labs Treatment |
Assocd w/DM 1 mroe often than DM2; due to inc'd insulin requirements from stress (infection)
Excess fat breakdown and inc'd ketogenesis from inc'd FFAs which are made into ketone bodies (beta-hydoxybutyrate>acetoacetate) Presentation: Kussmaul respirations (rapid/deep breathing) Delirium Fruity breath (due to exhaled acetone) Labs: Hyperglycemia, high H+, low HCO3-, inc'd blood ketone levels, hyperkalemia but depleted intracell K+ due to transcellular shift from insulin Tx: Fluids, insulin, and K+; glucose if necessary to prevent hypoglycemia |
|
Sulfonylureas:
Prefix/Suffix MOA AE |
Gli- (glyburide, glimepride, glipizide)
Close K+ channel in beta-cells, inc'd Ca2+ channel opening-->inc'd insulin release AE: Hypoglcyemia |
|
Metformin:
Drug Class AE |
Biguanide--MOA unknown
Dec'd gluconeogenesis, inc'd glycolysis, inc'd peripheral glucose uptake (insulin sensitivity) AE: lactic acidosis; contraindicated in renal failure (avoid if receiving IV contrast) |
|
Thiazolidinediones:
Prefix/Suffix MOA AE |
-glitazone
Inc insulin sensitivity in peripheral tissue; bind PPAR-gamma nuclear transcription factor AE: Weight gain, edema, hetpatox, cardiotox |
|
Exenatide:
Drug Class MOA |
GLP-1 analog
Increases insulin, decreases glucagon release |
|
Which diabetes drug:
AE: lactic acidosis |
metformin
|
|
Which diabetes drug:
AE: hypoglycemia |
sulfonylureas
|
|
Which diabetes drug:
Used in combination with any other oral agents |
metformin (first line)
|
|
Which diabetes drug:
Also lowers TGs and LDL |
metformin
|
|
Which diabetes drug:
Not safe in setting of hepatic dysfunction or CHF |
glitazones
metformin |
|
Which diabetes drug:
Should not be used in patients with elevated serum creatinine |
metformin
|
|
Which diabetes drug:
Should not be used in patients with liver cirrhosis, elevated serum creatinine, or inflammatory bowel disease |
alpha-glucosidase inhibitors--acarbose, miglitol
|
|
Which diabetes drug:
Hepatic serum transaminase levels should be monitored while using |
glitazones
metformin |
|
Which diabetes drug:
Not associated with weight gain, often used in overweight diabetics |
metformin
|
|
Which diabetes drug:
Metabolized by liver; excellent choice in patients with renal disease |
glitazones
|
|
Which diabetes drug:
Primarily affects postprandial hyperglycemia |
alpha-glucosidase inhibitors--acarbose, miglitol
|
|
Which diabetes drug:
MOA: closes K channel on beta-cells |
sulfonylureas
|
|
Which diabetes drug:
MOA: inhibits alpha-glucosidase ad intestinal brush border |
alpha-glucosidase inhibitors--acarbose, miglitol
|
|
Which diabetes drug:
MOA: agonist at PPAR-gamma receptors |
TZDs (glitazones)
|
|
28 year-old male with normally well-managed IDDM presents with DKA. He recently has acquired a cold and is taking OTC cold medicine.
Cause of DKA? |
Infection
|
|
How is hemoglobin glycosylated in DM to form HbA1c?
|
Non-enzymatic glycosylation
|
|
What are the main adverse effects of insulin therapy?
|
Hypoglycemia
Lipodystrophy Weight gain |
|
Metabolic syndrome:
Diagnosis |
3/5 of:
Abdominal obesity (men waist >40 in, women >35 in) TGs >150 HDL <40 in men, <50 in women BP >135/85 Fasting serum glucose >100 |
|
ADH:
Role |
Anti-diuresis-->retain free water, decreased serum sodium
|
|
SIADH:
Pathophys Presentation Treatment |
Excessive water retnetion, hyponatremia, urine osmolarity > serum osmolarity
Causes: ectopic ADH (small cell lung cancer), CNS disorders/head trauma, pulmonary disease Tx: Demeclocycline or water restriction CORRECT SODIUM LEVELS SLOWLY |
|
Diabetes insipidus:
Pathophys Presentation Treatment |
Intense thirst, polyuria, inability con concentrate urine owing to LACK OF ADH (central DI--pituitary tumor, trauma, sx) or to lack of renal response to ADH (nephrogenic DI--hereditary or due to hypecalcemia, Li, demeclocycline (ADH antag))
Tx: adequate fluid intake; for central DI: intranasal desmopressin (ADH analog), for nephrogenic DI--HCTZ, indomethacin, amiloride |
|
Zollinger-Ellison Syndrome:
Pathophys Presentation Treatment |
Gastrin-secreting tumor of pancreas or duodenum
Stomach shows rugal thickening with acid hypersecretion Causes recurrent ulcers Assocd w/MEN I Tx w/PPI, H2RA, Octreotide |
|
Wallenberg's Syndrome:
Pathophys Presentation |
Occlusion of PICA (posterior inferior cerebellar aa)-->unilateral infarct of lateral portion of rostral medulla
Results in loss of pain and tamp over contralateral body Loss of pain and temp over ipsilateral face Hoarseness, difficulty swallowing, loss of gag reflex Vertigo, nystagmus, n/v |
|
Which DM:
Associated with obesity |
2
|
|
Which DM:
May cause ketoacidosis |
1 (2 is a possibility but less likely)
|
|
Which DM:
Strong genetic predisposition |
2
|
|
Which DM:
Association with HLA DR3/4 |
1
|
|
Which tumor locations are associated with the 3 types of MEN disorders?
|
I: Pancreas, pituitary, parathyroid
IIA: Medullary thyroid carcinoma, pheo, parathy IIB: medullary thyroid carcinoma, pheo, mucosal neuroma |
|
What are the clinical manifestations of Addison's disease?
Cause? |
Inc'd skin pigmentation
hypotn maliase anorexia autoimmune-->adrenal atrophy; dec'd aldosterone, cortisol |
|
Which DM drug:
Lactic acidosis rare, but worrisome SE |
Metformin
|
|
Which DM drug:
SE: Hypoglycemia |
Sulfonylureas
|
|
Which DM drug:
MOA: closes K channel on beta cells |
Sulfonylureas
|
|
Which DM drug:
MOA: inhibits alpha-glucosidase at intestinal brush border |
alpha-glocusidase inhibitors
|
|
Which DM drug:
MOA: agonist at PPAR-gamma receptors |
glitizones
|
|
What is the mechanism of action of propylthirouracil?
What other drug works this way? AEs? |
Absnce of iodination of tyrosyl groups
Dec'd thyroid hormone synthesis Disrupts peripheral conversion of T4 to T3 METHIMAZOLE works this way AE: Agranulocytosis, aplastic anemia |
|
What cell type produces PTH?
|
PTH; chief cells of parathyroid
|
|
What cell type produces calcitonin?
|
Calcitonin: parafollicular C cells of thyroid
|
|
What cancers are associated with RET gene mutation?
|
MEN IIA
MEN IIB Medullary thyroid carcinoma Papillary thyroid carcinoma |
|
What are the symptoms of 21 alpha-hydroxylase deficiency?
|
Hypotn
Masculinization |
|
What are the symptoms of 11 beta-hydroxylase deficiency?
|
Hypertn
Masculinization |
|
Hormone affected:
Cushing's Syndrome |
Elevated cortisol
|
|
Hormone affected:
Conn's Syndrome |
Elevated aldosterone
|
|
Hormone affected:
Addison's Disease |
Dec'd aldosterone AND cortisol
|
|
Hormone affected:
Graves' Disease |
Inc'd T4
|
|
Cause of hyperthyroidism:
Tender thyroid gland |
Subacute (de Quairvain's--sp?) thyroiditis
|
|
Cause of hyperthyroidism:
Palpation of single thyroid nodule |
Toxic thyroid adenoma
|
|
Cause of hyperthyroidism:
Palpation of multiple thyroid nodules |
Toxic multinodular goiter
|
|
Cause of hyperthyroidism:
Eye changes: proptosis, edema, injection |
Graves'
|
|
Most common:
Chronic arrhythmia |
A fib
|
|
Most common:
Bacteria in GI tract |
Bacteroides fragilis
|
|
Most common:
Gynecologic malignancy |
Endometrial carcinoma
|
|
Most common:
Primary cardiac tumor in children |
Rhabdomyoma
|
|
Most common:
Breast cancer |
Invasive ductal carcinoma
|
|
Actinic keratosis
|
Precursor to squamous cell carcinoma
|
|
Acute gastric ulcer associated with CNS injury
|
Cushing's ulcer (inc'd ICP stimulates vagal gastric secretion)
|
|
Acute gastric ulcer associated with severe burns
|
Curling's ulcer (greatly reduced plasma volume results in sloughing of gastric mucosa)
|
|
Alternating areas of transmural inflammation and normal colon
|
Skip lesions--Crohn's dz
|
|
Aneurysm, dissecting
|
HTN
|
|
Aortic aneurysm, abdominal and descending aorta
|
Atherosclerosis
|
|
Aortic aneurysm, ascending
|
Teriary syphilis, Marfan's syndrome
|
|
Atrophy of mammillary bodies
|
Wernicke's encephalopathy (thiamine def. causing ataxia, ophtalmoplegia, confusion)
|
|
Autosplenectomy (fibrosis and shrinkage)
|
Sickle cell anemia
|
|
Bacteria associated with stomach cnacer
|
H pylori
|
|
Bacterial meningitis (adults and elderly)
|
Neisseria meningitidis
|
|
Bacterial meningitis (newborns and kids)
|
Group B strep (newborns)
Strep pnuemo/Neisseria meningitidis (kids) |
|
Benign melanocytic nevus
|
Spitz nevus--most common in first two decades
|
|
Bleeding disorder with GpIb deficiency
|
Bernard-Soulier disease (defect in platelet adhesion to vWF)
|
|
Brain tumor (adults)
|
Supratentorial: mets > astrocytoma (including glioblastoma multiforme) > meningioma > schwannoma
|
|
Brain tumor (kids)
|
infratentorial: medulloblastoma (cerebellum) or supratentorial: craniopharyngioma (cerebrum)
|
|
Breast cancer
|
Infiltrating ductal carcinoma (in US, 1 in 9 women will develop BrCa)
|
|
Breast mass
|
1. fibrocystic change
2. carcinoma--in postmenopausal women |
|
Breast tumor (benign)
|
Fibroadenoma
|
|
Cardiac primary tumor (kids)
|
Rhabdomyoma
|
|
Cardiac manifestation of lupus
|
Libman-Sacks endocarditis (nonbcaterial, affecting mitral)
|
|
Cardiac tumor (adults)
|
1. Mets
2. Primary myxoma |
|
Cerebellar tonsillar herniation
|
Chiari malformation (often presents with progressive hydrocephjalus or syringomyelia)
|
|
Chronic arrhythmia
|
A fib (assocd w/high risk emboli)
|
|
Chronic atrophic gastritis (autoimmune)
|
Predisposition to gastric carcinoma--can also cause pernicious anemia
|